title: Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.
abstract: Transforming growth factor β (TGF-β) physiologically induces Epstein-Barr virus (EBV) lytic infection by activating the expression of EBV's latent-lytic switch BZLF1 gene. Liang et al. (J. Biol. Chem. 277:23345-23357, 2002) previously identified a Smad-binding element (SBE) within the BZLF1 promoter, Zp; however, it accounts for only 20 to 30% of TGF-β-mediated activation of transcription from Zp. Here, we identified additional factors responsible for the rest of this activation. The incubation of EBV-positive MutuI cells with a TGF-β neutralizing antibody or inhibitors of the TGF-β type I receptor (TβRI) or Smad3 eliminated the TGF-β-induced reactivation of EBV. The coexpression of Smad2, Smad3, and Smad4 together with a constitutively active form of TβRI induced 15- to 25-fold transcription from Zp in gastric carcinoma AGS cells. By electrophoretic mobility shift assays, we identified four additional Smad-binding elements, named SBE2 to SBE5. Substitution mutations in individual SBEs reduced Smad-mediated activation of Zp by 20 to 60%; together, these mutations essentially eliminated it. Chromatin immunoprecipitation assays confirmed that Smad4 newly bound the Zp region of the EBV genome following the incubation of MutuI cells with TGF-β. SBE2 overlaps the ZEB-binding ZV silencing element of Zp. Depending upon posttranslational modifications, Smad4 either competed with ZEB1 for binding or formed a complex with ZEB1 on the Zp ZV element in a cell-free assay system. In transiently transfected cells, exogenously expressed ZEB1 inhibited Smad-mediated transcriptional activation from Zp. We conclude that TGF-β induces EBV lytic reactivation via the canonical Smad pathway by activating BZLF1 gene expression through multiple SBEs acting in concert.
authors: McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53706-1599, USA.
authors: Tawin
authors: T
authors: Iempridee
authors: Shreyasi
authors: S
authors: Das
authors: Iris
authors: I
authors: Xu
authors: Janet E
authors: JE
authors: Mertz
references: J Immunol. 2000 Sep 1;165(5):2500-10
references: 10946276
references: Immunity. 2000 Oct;13(4):497-506
references: 11070168
references: Int J Cancer. 1988 Aug 15;42(2):213-20
references: 2841246
references: J Virol. 2011 May;85(10):5081-90
references: 21389123
references: FEBS Lett. 2007 Apr 17;581(8):1617-24
references: 17391671
references: Arch Otorhinolaryngol. 1977 Dec 20;218(1-2):37-44
references: 341869
references: Nucleic Acids Res. 2001 Feb 1;29(3):732-42
references: 11160896
references: J Virol. 2010 Oct;84(19):10329-43
references: 20668090
references: J Biol Chem. 2000 Dec 15;275(50):39237-45
references: 11007770
references: Nature. 2003 Oct 9;425(6958):577-84
references: 14534577
references: Mol Cell Biol. 2004 Jul;24(14):6151-61
references: 15226419
references: J Virol. 2004 Nov;78(22):12308-19
references: 15507618
references: Mol Cell. 1998 Mar;1(4):611-7
references: 9660945
references: EMBO J. 2000 Oct 2;19(19):5178-93
references: 11013220
references: FEBS Lett. 2006 May 22;580(12):2811-20
references: 16678165
references: Cell. 2009 Jan 9;136(1):123-35
references: 19135894
references: Genes Dev. 2005 Dec 1;19(23):2783-810
references: 16322555
references: J Biol Chem. 2003 Dec 19;278(51):50833-42
references: 14514699
references: Semin Cancer Biol. 2009 Aug;19(4):252-60
references: 19505653
references: EMBO J. 2003 May 15;22(10):2443-52
references: 12743038
references: Arch Pathol Lab Med. 2004 Mar;128(3):282-91
references: 14987161
references: Trends Immunol. 2008 Apr;29(4):195-201
references: 18328785
references: J Gen Virol. 2009 Aug;90(Pt 8):2005-2014
references: 19420158
references: Virology. 1997 Feb 3;228(1):11-8
references: 9024805
references: Mol Pharmacol. 2006 Feb;69(2):597-607
references: 16288083
references: EMBO J. 1997 Jan 2;16(1):143-53
references: 9009275
references: EMBO J. 2000 Apr 17;19(8):1745-54
references: 10775259
references: Development. 2009 Nov;136(22):3699-714
references: 19855013
references: Virology. 2008 Aug 15;378(1):6-12
references: 18559281
references: Virus Genes. 1991 Apr;5(2):147-56
references: 1647567
references: J Virol. 1990 Mar;64(3):1217-26
references: 2154605
references: J Biol Chem. 2002 Dec 27;277(52):51008-16
references: 12374795
references: J Immunol. 1989 Mar 1;142(5):1536-41
references: 2537357
references: Mol Cell Biol. 1994 Dec;14(12):7770-81
references: 7969118
references: PLoS Pathog. 2007 Dec;3(12):e194
references: 18085824
references: J Virol. 2000 Jul;74(13):5810-8
references: 10846060
references: J Immunol. 1987 Jul 1;139(1):313-8
references: 2953817
references: Mol Biol Cell. 2007 Sep;18(9):3533-44
references: 17615296
references: J Gen Virol. 2000 Jun;81(Pt 6):1567-78
references: 10811940
references: J Virol. 2001 Jan;75(2):867-77
references: 11134300
references: J Biol Chem. 2003 Jul 25;278(30):27853-63
references: 12740389
references: Am J Physiol Cell Physiol. 2003 Oct;285(4):C823-30
references: 12801888
references: J Immunol. 1986 Dec 15;137(12):3855-60
references: 2878044
references: Cell. 1998 Sep 4;94(5):585-94
references: 9741623
references: J Exp Med. 1986 May 1;163(5):1037-50
references: 2871125
references: J Biol Chem. 1999 Nov 19;274(47):33412-8
references: 10559222
references: J Cell Physiol. 2001 Apr;187(1):117-23
references: 11241356
references: J Virol. 2010 Jun;84(12):6139-52
references: 20375168
references: Oncogene. 2008 Feb 21;27(9):1218-30
references: 17724470
references: Biochem J. 2000 Oct 1;351(Pt 1):95-105
references: 10998351
references: Mol Cell Biol. 1999 Jan;19(1):21-30
references: 9858528
references: J Biol Chem. 2001 May 11;276(19):16573-9
references: 11278686
references: J Biol Chem. 2002 Jun 28;277(26):23345-57
references: 11971895
references: J Biol Chem. 2001 Feb 2;276(5):2975-8
references: 11096122
references: EMBO J. 2003 May 15;22(10):2453-62
references: 12743039
references: Cell. 2004 Apr 16;117(2):211-23
references: 15084259
references: Cell Signal. 2004 Jan;16(1):31-41
references: 14607273
references: Mol Cell Biol. 2009 Jan;29(1):172-86
references: 18955504
references: Oncogene. 2010 Jul 22;29(29):4157-69
references: 20514018
references: Protein Expr Purif. 2011 Apr;76(2):145-53
references: 21126607
references: Clin Exp Allergy. 2009 May;39(5):626-39
references: 19422105
references: EMBO Rep. 2002 Feb;3(2):141-6
references: 11818339
references: Mol Pharmacol. 2002 Jul;62(1):65-74
references: 12065756
references: J Virol. 2001 Mar;75(5):2388-99
references: 11160742
references: J Virol. 1995 Jul;69(7):4158-65
references: 7769675
references: Cancer Res. 2005 Nov 15;65(22):10431-40
references: 16288034
references: J Biol Chem. 2009 Sep 4;284(36):23912-24
references: 19589780
references: J Virol. 2003 Jan;77(1):199-207
references: 12477825
references: J Biol Chem. 2000 Nov 24;275(47):36803-10
references: 10969078
references: J Virol. 2007 Sep;81(18):10113-22
references: 17626078
references: Mol Cell Biol. 1991 Oct;11(10):5229-43
references: 1922043
references: Methods. 2002 Jan;26(1):37-47
references: 12054903
references: Oncogene. 2007 Oct 25;26(49):6979-88
references: 17486063
references: Blood. 2008 May 1;111(9):4731-40
references: 18199825
references: Neoplasia. 2004 Sep-Oct;6(5):603-10
references: 15548370